The Hypertension Training Program provides comprehensive, curriculum- and mentor- based research training in hypertension at the molecular, cellular, whole animal, translational, patient-oriented and population-oriented levels by continuing the process that began five years ago that integrated the resources of the Brigham and Women's Hospital (BWH) and the Morehouse School of Medicine (MSM) into a cohesive single, two site program. The training program is mature, being 35 years old, with nearly 2/3's of the preceptors serving longer than 5 years. Yet, also it is dynamic with 1/3 of the preceptors being new to the program. Administratively, the program is guided by three committees: Steering Committee (responsible for overall program structure and function);Mentoring Committee (responsible for the mentoring relationships);and Individual Research Committee (functions like a thesis committee). The Program is divided into five components. (1) The introductory course is a broad survey-type activity consisting of lectures and seminars that provide all trainees with broad exposure to endocrine, renal and cardiovascular physiology and pathophysiology, vascular biology, laboratory and patient-oriented research human subjects and animal care and ethics. (2) Mentor-guided research project(s) begin with trainees (with Mentoring Committee guidance) choosing one of the following broad training tracts: Patient/Population-Oriented Research;Human Genetics;or Bench Research, as well as (a) mentor(s). Trainees gain experience in diverse areas such as ethics of medical research, molecular biology, transgenic technology, signal transduction, receptor techniques, human and animal genetics, vascular biology, nutrition and detailed assessment of the factors regulating blood pressure at the cell, animal and human levels. (3) In their second year trainees are encouraged to participate in a degree program leading to a master in medical science or public health or a PhD. (4) On-going activities in this interdisciplinary, translational research program include the availability of co-mentors with specialized complementary expertise, an exchange program between MSM and BWH, a variety of lectures and seminars and rounds in which the trainee can give a presentation. (5) The program includes individual career guidance and mentoring with formal evaluations of the trainees, mentors and the program. Trainee selection criteria are: letters of recommendation, previous training experience, research interests, and the results of a personal interview. During the past 10 years, approximately 40% of entering trainees had an MD plus another degree or a PhD, with 10 MDs obtaining a second degree while in the training program. Under-representative minorities comprised 17% of the trainees during the past 10 years and 25% during the past 5 years. In the past 10 years, 90% of completers of the program have careers in research, teaching and/or administration in academia, government or industry. Funds are requested to continue to support eight post-doctoral trainees.

Public Health Relevance

The primary mission of the Training Program in Hypertension is to nurture the development of individuals who will provide leadership roles in research, administration and teaching in academia, government and industry. To accomplish this mission the Program has recruited outstanding mentors committed to providing the type of environment that fosters the development of individual creativity, rigorous scientific growth and strong interpersonal skills. The trainees and mentors are linked in a program that has outstanding institutional educational and infrastructure support to successfully accomplish its overall mission of developing the next generation of highly skilled bench, translational and clinical researchers.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007609-28
Application #
8703744
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Wang, Wayne C
Project Start
1991-07-01
Project End
2018-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
28
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Nicklas, Jacinda M; Skurnik, Geraldine; Zera, Chloe A et al. (2016) Employing a Multi-level Approach to Recruit a Representative Sample of Women with Recent Gestational Diabetes Mellitus into a Randomized Lifestyle Intervention Trial. Matern Child Health J 20:261-9
Rao, Ajay D; Bonyhay, Istvan; Dankwa, Joel et al. (2016) Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control. Diabetes 65:209-15
Baudrand, Rene; Pojoga, Luminita; Vaidya, Anand et al. (2016) Response to Letter Regarding Article, ""Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects"". Circulation 133:e606
Pojoga, Luminita H; Yao, Tham M; Opsasnick, Lauren A et al. (2015) Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury. J Pharmacol Exp Ther 355:32-47
Garza, Amanda E; Pojoga, Luminita H; Moize, Burhanuddin et al. (2015) Critical Role of Striatin in Blood Pressure and Vascular Responses to Dietary Sodium Intake. Hypertension 66:674-80
Garza, Amanda E; Rariy, Chevon M; Sun, Bei et al. (2015) Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans. Hypertension 65:211-7
Garg, Rajesh; Rao, Ajay D; Baimas-George, Maria et al. (2015) Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes 64:236-42
Sarma, Asha; Shyn, Paul B; Vivian, Mark A et al. (2015) Single-Session CT-Guided Percutaneous Microwave Ablation of Bilateral Adrenal Gland Hyperplasia Due to Ectopic ACTH Syndrome. Cardiovasc Intervent Radiol 38:1335-8
Zaheer, Sarah; LeBoff, Meryl; Lewiecki, E Michael (2015) Denosumab for the treatment of osteoporosis. Expert Opin Drug Metab Toxicol 11:461-70
Baudrand, Rene; Pojoga, Luminita H; Vaidya, Anand et al. (2015) Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects. Circulation 132:1825-33

Showing the most recent 10 out of 164 publications